In last trading session, Tandem Diabetes Care Inc (NASDAQ:TNDM) saw 0.45 million shares changing hands with its beta currently measuring 1.34. Company’s recent per share price level of $31.62 trading at $0.4 or 1.28% at ring of the bell on the day assigns it a market valuation of $2.08B. That closing price of TNDM’s stock is at a discount of -69.8% from its 52-week high price of $53.69 and is indicating a premium of 41.65% from its 52-week low price of $18.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.53 million shares which gives us an average trading volume of 1.35 million if we extend that period to 3-months.
For Tandem Diabetes Care Inc (TNDM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.78. Splitting up the data highlights that, out of 10 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Upright in the green during last session for gaining 1.28%, in the last five days TNDM remained trading in the green while hitting it’s week-highest on Friday, 11/29/24 when the stock touched $31.62 price level, adding 0.44% to its value on the day. Tandem Diabetes Care Inc’s shares saw a change of 6.90% in year-to-date performance and have moved 2.86% in past 5-day. Tandem Diabetes Care Inc (NASDAQ:TNDM) showed a performance of -2.29% in past 30-days. Number of shares sold short was 7.38 million shares which calculate 4.72 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 58 to the stock, which implies a rise of 45.48% to its current value. Analysts have been projecting 36 as a low price target for the stock while placing it at a high target of 160. It follows that stock’s current price would drop -13.85% in reaching the projected high whereas dropping to the targeted low would mean a loss of -13.85% for stock’s current value.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Statistics highlight that Tandem Diabetes Care Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -38.28% of value to its shares in past 6 months, showing an annual growth rate of -7.01% while that of industry is 15.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 21.59% from the last financial year’s standing.
18 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 251.52M for the same. And 13 analysts are in estimates of company making revenue of 221.94M in the next quarter. Company posted 196.8M and 191.67M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.11% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 50.64% while estimates for its earnings growth in next 5 years are of 16.00%.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Insiders are in possession of 0.77% of company’s total shares while institution are holding 114.16 percent of that, with stock having share float percentage of 115.04%. Investors also watch the number of corporate investors in a company very closely, which is 114.16% institutions for Tandem Diabetes Care Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at TNDM for having 11.12 million shares of worth $448.14 million. And as of 2024-06-30, it was holding 17.1137 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 7.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.3518 of outstanding shares, having a total worth of $297.26 million.
On the other hand, iShares Core S&P Smallcap ETF and Smallcap World Fund are the top two Mutual Funds which own company’s shares. As of Aug 31, 2024 , the former fund manager was holding 4.32 shares of worth $132.43 million or 6.58% of the total outstanding shares. The later fund manager was in possession of 4.27 shares on Jun 30, 2024 , making its stake of worth around $130.84 million in the company or a holder of 6.50% of company’s stock.
